781 results on '"Mandrup-Poulsen, Thomas"'
Search Results
52. Histone Deacetylase (HDAC) Inhibition as a Novel Treatment for Diabetes Mellitus
53. The Oral Histone Deacetylase Inhibitor ITF2357 Reduces Cytokines and Protects Islet β Cells In Vivo and In Vitro
54. Total and cause-specific mortality by elevated transferrin saturation and hemochromatosis genotype in individuals with diabetes: two general population studies
55. Interleukin-1 Antagonism: A Sturdy Companion for Immune Tolerance Induction in Type 1 Diabetes?
56. Need for Reclassification of Diabetes Secondary to Iron Overload in the ADA and WHO Classifications
57. Additional file 1 of Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials
58. Interleukin-1-receptor antagonist in type 2 diabetes mellitus
59. The Fas pathway is involved in pancreatic [beta] cell secretory function
60. Proinflammatory Cytokines Perturb Mouse and Human Pancreatic Islet Circadian Rhythmicity and Induce Uncoordinated β-Cell Clock Gene Expression via Nitric Oxide, Lysine Deacetylases, and Immunoproteasomal Activity
61. Mitophagy protects β cells from inflammatory damage in diabetes
62. Author Correction: A guiding map for inflammation
63. GPR183 Regulates Interferons, Autophagy, and Bacterial Growth During Mycobacterium tuberculosis Infection and Is Associated With TB Disease Severity
64. Enhancer of Zeste Homolog 2 (EZH2) Mediates Glucolipotoxicity-Induced Apoptosis in β-Cells
65. Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes
66. Total Mortality by Elevated Transferrin Saturation in Patients With Diabetes
67. Serum adipokines as biomarkers of beta-cell function in patients with type 1 diabetes: positive association with leptin and resistin and negative association with adiponectin
68. Bone Morphogenetic Protein 4 Inhibits Insulin Secretion in Rat Islets
69. Celebrities in the heart, strangers in the pancreatic beta cell: Voltage‐gated potassium channels Kv7.1 and Kv11.1 bridge long QT syndrome with hyperinsulinaemia as well as type 2 diabetes.
70. The intercellular adhesion molecule-1 K469E polymorphism in type 1 diabetes
71. Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
72. Response to Comment on: Ellervik et al. Elevated Transferrin Saturation and Risk of Diabetes: Three Population-Based Studies. Diabetes Care 2011;34: 2256–2258
73. Perspective: Testing failures
74. RNA modifications by oxidation: A novel disease mechanism?
75. Synergistic Reversal of Type 1 Diabetes in NOD Mice With Anti-CD3 and Interleukin-1 Blockade: Evidence of Improved Immune Regulation
76. Elevated Transferrin Saturation and Risk of Diabetes: Three population-based studies
77. Apolipoprotein CIII Reduces Proinflammatory Cytokine-Induced Apoptosis in Rat Pancreatic Islets via the Akt Prosurvival Pathway
78. Cytokines and Type 1 Diabetes: A Numbers Game
79. Neuromedin U Does Not Act as a Decretin in Rats
80. GPR183 regulates interferons and bacterial growth during Mycobacterium tuberculosis infection: interaction with type 2 diabetes and TB disease severity
81. The Connexin 43 Regulator Rotigaptide Reduces Cytokine-Induced Cell Death in Human Islets
82. Combination of ferric ammonium citrate with cytokines involved in apoptosis and insulin secretion of human pancreatic beta cells related to diabetes in thalassemia
83. Mitophagy protects beta cells from inflammatory damage in diabetes
84. The inducible β5i proteasome subunit contributes to proinsulin degradation in GRP94-deficient β-cells and is overexpressed in type 2 diabetes pancreatic islets
85. The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, low concentrations of interleukin 1 β
86. Blockade of interleukin 1 in type 1 diabetes mellitus
87. The oral histone deacetylase inhibitor ITF2357 reduces cytokine production, cytokine activities and protects islet β-cells in vivo and in vitro
88. Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
89. Inhibition of Nuclear Factor-κB or Bax Prevents Endoplasmic Reticulum Stress- But Not Nitric Oxide-Mediated Apoptosis in INS-1E Cells
90. Proinflammatory Cytokines Activate the Intrinsic Apoptotic Pathway in β-Cells
91. G Protein-Coupled Receptor 39 Deficiency Is Associated with Pancreatic Islet Dysfunction
92. Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes
93. The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus
94. Cytokines and β-Cell Biology: from Concept to Clinical Translation
95. No direct effect of sodium-glucose transporter-2 (SGLT2) activity on glucagon secretion
96. Interleukin-1-Receptor Antagonist in Type 2 Diabetes Mellitus
97. Diabetes and Suppressors of Cytokine Signaling Proteins
98. Cytokine-Induced Proapoptotic Gene Expression in Insulin-Producing Cells Is Related to Rapid, Sustained, and Nonoscillatory Nuclear Factor-κB Activation
99. Suppressor of Cytokine Signaling-3 Inhibits Interleukin-1 Signaling by Targeting the TRAF-6/TAK1 Complex
100. Interleukin-6 and Diabetes: The Good, the Bad, or the Indifferent?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.